Stock data
Elicio Therapeutics, Inc. (ELTX)
Elicio Therapeutics, Inc. (ELTX) reported net income of -US$39.57M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$37.71M | -US$39.57M | — |
| 2024 | — | — | -US$44.99M | -US$51.90M | — |
| 2023 | — | — | -US$35.74M | -US$35.20M | — |
| 2022 | US$2.30M | — | -US$23.73M | -US$28.21M | — |
| 2021 | US$28.31M | — | -US$39.31M | -US$54.57M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$8.22M | — |
| 2026-03-31 | — | -US$11.82M | — |
| 2025-12-31 | — | -US$7.72M | — |
| 2025-09-30 | — | -US$10.08M | — |
| 2025-06-30 | — | -US$10.56M | — |
| 2025-03-31 | — | -US$11.21M | — |
| 2024-12-31 | — | -US$14.00M | — |
| 2024-09-30 | — | -US$18.84M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.